These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11785088)

  • 21. Prostate-specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo.
    Denmeade SR; Litvinov I; Sokoll LJ; Lilja H; Isaacs JT
    Prostate; 2003 Jun; 56(1):45-53. PubMed ID: 12746846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
    Vural B; Ozkan S; Bodur H
    J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence and enzymatic activity of prostate-specific antigen in archival prostate cancer samples.
    Vukmirovic-Popovic S; Escott NG; Duivenvoorden WC
    Oncol Rep; 2008 Oct; 20(4):897-903. PubMed ID: 18813833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
    Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
    Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H; Akakura K; Igarashi T; Ueda T; Ito H; Watanabe M; Nomura F; Ochiai T; Shimada H
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen in breast disease.
    Poh BH; Jayaram G; Sthaneshwar P; Yip CH
    Malays J Pathol; 2008 Jun; 30(1):43-51. PubMed ID: 19108411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate-specific antigen value as a marker in breast cancer.
    Narita D; Cimpean AM; Anghel A; Raica M
    Neoplasma; 2006; 53(2):161-7. PubMed ID: 16575473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.
    Michel S; Collomb-Clerc E; Geourjon C; Charrier JP; Passagot J; Courty Y; Deléage G; Jolivet-Reynaud C
    J Mol Recognit; 2005; 18(3):225-35. PubMed ID: 15593306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma.
    Diamandis EP; Okui A; Mitsui S; Luo LY; Soosaipillai A; Grass L; Nakamura T; Howarth DJ; Yamaguchi N
    Cancer Res; 2002 Jan; 62(1):295-300. PubMed ID: 11782391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer.
    Lai LC; Erbas H; Lennard TW; Peaston RT
    Int J Cancer; 1996 Jun; 66(6):743-6. PubMed ID: 8647643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer.
    Sauter ER; Klein G; Wagner-Mann C; Diamandis EP
    Cancer Detect Prev; 2004; 28(1):27-31. PubMed ID: 15041074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonprostatic sources of prostate-specific antigen.
    Diamandis EP; Yu H
    Urol Clin North Am; 1997 May; 24(2):275-82. PubMed ID: 9126224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and purification of recombinant active prostate-specific antigen from Escherichia coli.
    Jeong S; Lee SW
    J Microbiol Biotechnol; 2007 May; 17(5):840-6. PubMed ID: 18051307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
    Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
    Raaijmakers R; de Vries SH; Blijenberg BG; Wildhagen MF; Postma R; Bangma CH; Darte C; Schröder FH
    Eur Urol; 2007 Nov; 52(5):1358-64. PubMed ID: 17499425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
    Kuruma H; Egawa S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):11-5. PubMed ID: 12557698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate-specific antigen/prostatic acid phosphatase ratio is significant prognostic factor in patients with stage IV prostate cancer.
    Saito T; Hara N; Kitamura Y; Komatsubara S
    Urology; 2007 Oct; 70(4):702-5. PubMed ID: 17991541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New circulating biomarkers for prostate cancer.
    Bensalah K; Lotan Y; Karam JA; Shariat SF
    Prostate Cancer Prostatic Dis; 2008; 11(2):112-20. PubMed ID: 17998918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate specific antigen in the female body: its role in breast cancer prognosis.
    Ulutin HC; Pak Y
    Radiat Med; 2000; 18(5):273-6. PubMed ID: 11128396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer.
    Gandhok NK; Looney S; Koochekpour S; Sartor O
    Urol Oncol; 2005; 23(3):163-7. PubMed ID: 15907715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.